Avricore Health Secures $1.25M Private Placement to Address Going Concern
AVCRF has more than doubled off its 52-week low of $0.017.
Summary
Avricore Health announced a $1.25 million private placement at $0.05 per unit, including warrants, to fund operations and expansion following a recent going concern warning.
Key Events · Financing and Capital Events · AVCRF
-
$1.25 Million Private Placement Announced
The company is raising up to $1.25 million through a non-brokered private placement, issuing units at $0.05 each.
-
Significant Potential Dilution
The offering, including shares from units and associated warrants, could result in approximately 37% dilution to existing shareholders.
-
Addresses Going Concern Warning
This capital raise is vital for the company's survival, coming shortly after its auditor issued a going concern warning on May 8, 2026.
-
Warrant Terms Included
Each unit includes one common share and one-half transferable share purchase warrant, exercisable at $0.10 for 24 months.
Analysis · AVCRF · Life Sciences
Avricore Health Inc. announced a non-brokered private placement to raise up to $1.25 million by issuing units at $0.05 each. Each unit includes one common share and one-half warrant, with warrants exercisable at $0.10 for 24 months. This financing is critical for the company, especially following a recent going concern warning from its auditor. While the offering is highly dilutive, potentially increasing outstanding shares by approximately 37%, it provides essential capital for expanding the HealthTab™ network and for general working capital, which is crucial for the company's immediate operational viability.
At the time of this filing, AVCRF was trading at $0.05 on OTC in the Life Sciences sector, with a market capitalization of approximately $5M. The 52-week trading range was $0.02 to $0.08. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.